ENTITY
Wuxi Biologics

Wuxi Biologics (2269 HK)

408
Analysis
Health CareChina
WuXi Biologics (Cayman) Inc. is a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China, U.S., and Iceland. We provide a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. Our services are designed to help our global partners in shortening the cycle and lowering the cost of drug and medical device R&D through cost-effective and efficient solutions.
more
Refresh
Exchange Announcement23 Apr 2024 21:23
Exchange Announcement22 Apr 2024 20:53
Exchange Announcement19 Apr 2024 21:14
Exchange Announcement16 Apr 2024 20:21
Exchange Announcement11 Apr 2024 22:06
x